ABBV: AbbVie Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 328,692.28
Enterprise Value ($M) 393,583.28
Book Value ($M) 3,364.00
Book Value / Share 1.90
Price / Book 97.71
NCAV ($M) -107,028.00
NCAV / Share -60.59
Price / NCAV -3.07

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.03
Return on Equity (ROE) 0.40

Liquidity (mrq)
Quick Ratio 0.64
Current Ratio 0.76

Balance Sheet (mrq) ($M)
Current Assets 27,675.00
Assets 136,165.00
Liabilities 134,703.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 56,334.00
Operating Income 18,317.00
Net Income 4,278.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 18,806.00
Cash from Investing -20,820.00
Cash from Financing -5,211.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 854,094 4,847,846 17.62
2025-05-29 772,373 3,614,005 21.37
2025-05-28 689,675 3,667,970 18.80
2025-05-27 533,617 3,758,341 14.20

(click for more detail)

Similar Companies
ABT – Abbott Laboratories ADCT – ADC Therapeutics SA


Financial data and stock pages provided by
Fintel.io

Finpedia: AbbVie Inc.